Enlitic Inc

Enlitic Inc

ENL · AU · Healthcare / Health Information Services

0.032AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.032
Open0.032
Day Range0.032 – 0.032
52-Week Range0.034 – 0.45
Volume10
Market Cap26.89M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.26
Dividend Yield0.00%
Beta-0.43
50-Day Avg0.0445
200-Day Avg0.0826

About

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization solution designed to de-identify protected health information from medical imaging data; and Migratek, an AI-enabled data migration solution, as well as routing services. The company provides its solutions to radiologists, IT professionals, executives, and researchers; and training services to PACS administrators, IT supervisors, system administrators, radiologists, and technologists. The company was formerly known as You Partners, Inc. Enlitic, Inc. was incorporated in 2014 and is based in Loveland, Colorado.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Michael Karlgerhard Sistenich B.Sc, M.Sc.
  • Employees0
  • Headquarters1635 Foxtrail Drive, Loveland, CO, United States, 80538, Australia
  • Websitehttps://enlitic.com

Leadership

  • Mr. Michael Karlgerhard Sistenich B.Sc, M.Sc.CEO & Executive Director · b. 1975
  • Mr. Darren ScottiCFO & Company Secretary
  • Mr. Dan KozimorChief Technology Officer
  • Mr. Scott StantonVice President of Sales Operations
  • Mr. Steve RankinChief Strategy Officer

Financials

Income Statement

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Total Revenue903.74K495.92K1.08M3.83M
Growth (%)--45.13%+117.55%+255.13%
Gross Profit-495.92K1.08M3.80M
Gross Margin-100.00%100.00%99.08%
Operating Expense-16.05M16.97M17.11M
Operating Income-17.56M-15.56M-15.89M-13.32M
Operating Margin-1943.12%-3137.17%-1472.69%-347.53%
EBITDA--15.10M-15.09M-12.63M
EBITDA Margin--3045.33%-1398.77%-329.78%
Net Income-25.04M-15.55M-15.24M-13.37M
Net Income Margin-2770.80%-3135.89%-1412.41%-349.07%
Interest Expense-53.15K23038.33K
Interest Expense % of Total Revenue-10.72%0.02%1.00%

Balance Sheet

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Total Assets3.10M11.57M14.20M8.96M
Total Liabilities30.76M633.43K3.17M4.88M
Total Equity-27.66M10.94M11.03M4.08M
Cash2.22M11.09M7.16M2.57M
Total Debt--312.38K-
Net Debt--11.09M-6.84M-

Cash Flow

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-16.57M-14.88M-15.17M-11.79M
Investing Cash Flow-175.46K545-3.12M14.57K
Financing Cash Flow7.16M23.72M14.45M7.71M
Capital Expenditure175.46K4.58K20.92K12.93K
Free Cash Flow--14.88M-15.19M-11.80M
FCF to OCF-100.03%100.14%100.11%

Earnings

Report DateFeb 28, 2025May 5, 2025Aug 27, 2025Dec 3, 2025Feb 26, 2026
EPS Estimate0.000.000.000.000.00
EPS Actual-0.030.00-0.010.000.00
Surprise-----
Timing-----

Key Statistics & Ratios

Market Cap26.89M
Enterprise Value28.17M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales7.47
Price / Book5.33
EPS-0.26
Book Value-0.0462
Revenue (TTM)3.60M
Gross Profit (TTM)-7.27M
EBITDA-11.23M
Profit Margin0.00%
Operating Margin-334.85%
Return on Equity-349.07%
Return on Assets-67.39%
Shares Outstanding726.80M
Shares Float36.73M
Beta-0.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 11, 20261:10